Antibody Drug Conjugates Market

Antibody Drug Conjugates Market, By Product Type (Adcetris, Kadcyla, Enhertu, Trodelvy, Padcev, Others), By Linker Type (Non-cleavable Linker, Cleavable Linker), By Application (Blood Cancer, Breast Cancer, Ovary Cancer, Lung Cancer, Skin Cancer, Brain Tumor, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-commerce), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Antibody Drug Conjugate (ADC) is typically made up of a monoclonal antibody (mAb) covalently attached to a cytotoxic drug via a chemical linker. It combines the advantages of highly specific targeting ability and a highly potent killing effect to achieve accurate and efficient elimination of cancer cells, making it one of the hotspots for anticancer drug research and development. Since the approval of the first ADC, Padcev (gemtuzumab ozogamicin) in 2000 by the U.S. Food and Drug Administration (FDA), till now 14 ADCs have been approved for market use worldwide. Furthermore, over 100 ADC candidates are currently being studied in clinical stages. Antibody-drug conjugates attach highly potent cytotoxic anticancer agents to monoclonal antibodies via biodegradable, stable linkers and discriminate between cancer and normal tissue. These linkers are either cleavable or non-cleavable. Linker technology advancements are required to attach monoclonal antibodies to cytotoxic anticancer agents, allowing control over drug pharmacokinetics and significantly improving cytotoxic agent delivery to cancer cells. The specific binding of the targeting antibody-drug conjugate to the specific tumor antigen and the internalization of the antigen-antibody complex to ensure focused delivery of the conjugated cytotoxic agent inside tumor cells are critical to the efficacy of antibody-targeted chemotherapy.

Market Dynamics

Approvals of novel ADC candidates for the treatment of cancer are anticipated to support the market growth over the forecasted period. For instance, on February 3, 2023, Gilead Sciences, Inc., a pharmaceutical firm, announced that the U.S. Food and Drug Administration (FDA) granted approval for Trodelvy (sacituzumab govitecan-hziy) to be used in treating adult patients afflicted with inoperable locally advanced or metastatic breast cancer that is hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative (IHC 0, IHC 1+, or IHC 2+/ISH-). These patients should have previously undergone endocrine-based therapy and received a minimum of two additional systemic therapies in the metastatic phase.

Key features of the study:
  • This report provides an in-depth analysis of the global antibody drug conjugates market and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global antibody drug conjugates market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • The key companies covered as a part of this study include AstraZeneca PLC, Daiichi Sankyo Company, Limited, Novasep, ADC Therapeutics SA, Alentis Therapeutics AG, F. Hoffmann-La Roche, Gilead Sciences, Inc., AbbVie Inc., Biosion USA, Inc., Astellas Pharma Inc., Duality Biologics (Suzhou) Co. Ltd., BioNTech SE, LaNova Medicines Ltd., Bliss Biopharmaceutical, Eisai Co., Ltd., ProfoundBio, Pfizer, Inc., ImmunoGen Inc., Mersana Therapeutics Inc., Sorrento Therapeutics Inc., Oxford BioTherapeutics Ltd, and Takeda Pharmaceutical Company Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global antibody drug conjugates market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antibody drug conjugates market
Detailed Segmentation:
  • By Product Type:
  • Adcetris
  • Kadcyla
  • Enhertu
  • Trodelvy
  • Padcev
  • Others (Blenrep, Tivdak, Zynlota, Elahere, etc.)
  • By Linker Type:
  • Non-cleavable Linker
  • Cleavable Linker
  • By Application:
  • Blood Cancer
  • Breast Cancer
  • Ovary Cancer
  • Lung Cancer
  • Skin Cancer
  • Brain Tumor
  • Others (Renal Caner, Urothelial & Bladder Cancer, etc.)
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • E-commerce
  • By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • Company Profiles
  • AstraZeneca PLC
  • Daiichi Sankyo Company, Limited
  • Novasep
  • ADC Therapeutics SA
  • Alentis Therapeutics AG
  • F. Hoffmann-La Roche
  • Gilead Sciences, Inc.
  • AbbVie Inc.
  • Biosion USA, Inc.
  • Astellas Pharma Inc.
  • Duality Biologics (Suzhou) Co. Ltd.
  • BioNTech SE
  • LaNova Medicines Ltd.
  • Bliss Biopharmaceutical
  • Eisai Co., Ltd.
  • ProfoundBio
  • Pfizer, Inc.
  • ImmunoGen Inc.
  • Mersana Therapeutics Inc.
  • Sorrento Therapeutics Inc.
  • Oxford BioTherapeutics Ltd
  • Takeda Pharmaceutical Company Ltd


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Product Type
Market Snippet, By Linker Type
Market Snippet, By Application
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis
4. Global Antibody Drug Conjugates Market - COVID-19 Impact Analysis
Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand
5. Global Antibody Drug Conjugates Market, By Product Type, 2018 - 2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 - 2030
Segment Trends
Adcetris
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends
Kadcyla
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends
Besponsa
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends
Lumoxiti
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends
Mylotarg
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends
Others (Polivy, Lumoxiti, Zynlonta, etc.)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends
6. Global Antibody Drug Conjugates Market, By Linker Type, 2018 - 2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 - 2030
Segment Trends
Non-Cleavable Linker
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends
Cleavable Linker
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends
7. Global Antibody Drug Conjugates Market, By Application, 2018 - 2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 - 2030
Segment Trends
Blood Cancer
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 - 2030
Segment Trends
Breast Cancer
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 - 2030
Segment Trends
Ovary Cancer
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 - 2030
Segment Trends
Lung Cancer
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 - 2030
Segment Trends
Skin Cancer
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 - 2030
Segment Trends
Brain Tumor
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 - 2030
Segment Trends
Others
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 - 2030
Segment Trends
8. Global Antibody Drug Conjugates Market, By Distribution Channel , 2018 - 2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 - 2030
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
E-commerce
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
9. Global Antibody Drug Conjugates Market, By Region, 2018 - 2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 - 2030
Segment Trends
North America
Introduction
Market Size and Forecast, Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Linker Type, 2018 - 2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel , 2018 - 2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Linker Type, 2018 - 2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel , 2018 - 2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Linker Type, 2018 - 2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel , 2018 - 2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Linker Type, 2018 - 2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel , 2018 - 2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Linker Type, 2018 - 2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel , 2018 - 2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Linker Type, 2018 - 2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel , 2018 - 2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
North Africa
Central Africa
South Africa
10. Competitive Landscape
Company Profiles
AstraZeneca PLC
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Daiichi Sankyo Company, Limited
Novasep
ADC Therapeutics SA
Alentis Therapeutics AG
F. Hoffmann-La Roche
Gilead Sciences, Inc.
AbbVie Inc.
Biosion USA, Inc.
Astellas Pharma Inc.
Duality Biologics (Suzhou) Co. Ltd.
BioNTech SE
LaNova Medicines Ltd.
Bliss Biopharmaceutical
Eisai Co., Ltd.
ProfoundBio
Pfizer, Inc.
ImmunoGen Inc.
Mersana Therapeutics Inc.
Sorrento Therapeutics Inc.
Oxford BioTherapeutics Ltd
Takeda Pharmaceutical Company Ltd
11. Section
References
Research Methodology
About us and Sales Contact
*Browse 44 market data tables and 42 figures on “Global Antibody Drug Conjugates Market” – Global forecast to 2030

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings